Oxford Biodynamics Plc Stock Today
| OXBOF Stock | USD 0 0.01 60.00% |
PerformanceVery Weak
| Odds Of DistressAbout Average
|
Oxford BioDynamics is trading at 0.004 as of the 22nd of March 2025. This is a 60 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.004. Oxford BioDynamics has 49 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom. The company has 146.71 M outstanding shares. More on Oxford BioDynamics Plc
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Oxford Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Oxford BioDynamics Plc [OXBOF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oxford BioDynamics's market, we take the total number of its shares issued and multiply it by Oxford BioDynamics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oxford BioDynamics Plc classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 146.71 M outstanding shares.
Oxford BioDynamics Plc has accumulated about 4.59 M in cash with (5.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Oxford BioDynamics Probability Of Bankruptcy
Ownership AllocationOxford BioDynamics owns a total of 146.71 Million outstanding shares. Over half of Oxford BioDynamics' outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Oxford Ownership Details
Oxford BioDynamics Plc Risk Profiles
| Mean Deviation | 1.79 | |||
| Standard Deviation | 7.39 | |||
| Variance | 54.55 | |||
| Risk Adjusted Performance | (0.10) |
Oxford Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oxford BioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Oxford BioDynamics Corporate Management
| MA FCA | CFO Director | Profile | |
| T Demain | Company Sec | Profile | |
| Sandy Primrose | Technical Consultant | Profile | |
| BSc BSC | CDO | Profile | |
| Alexandre Ma | Chief Director | Profile | |
| Thomas BA | Chief Officer | Profile | |
| Jayne BSc | Director Operations | Profile |
Other Information on Investing in Oxford Pink Sheet
Oxford BioDynamics financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford BioDynamics security.